Harmonized System
U.S. exports of Medicaments Containing Penicillins or Penicillin Derivatives (HS 300310) totaled $97K in August 2026, exported to 4 countries.
Last updated: August 2026 dataPenicillin-based medicaments — including ampicillin, amoxicillin, and other beta-lactam derivatives — are bulk pharmaceutical preparations not put up in measured doses for retail sale, used primarily as active pharmaceutical ingredients (APIs) or intermediate formulations in drug manufacturing. Austria and Italy are the leading US source countries, with China and India also significant suppliers — a supply chain that reflects both European finished-drug manufacturing and Asian API production. FDA's Center for Drug Evaluation and Research (CDER) governs admissibility, and all foreign manufacturing facilities must be registered with FDA and subject to inspection. Importers should note that penicillin-class APIs from certain origins have historically attracted FDA import alerts for cGMP non-compliance.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
An FDA import alert authorizes FDA field offices to detain shipments from a specific manufacturer or country without physical examination, based on prior evidence of cGMP violations or adulteration. Penicillin API suppliers — particularly from Asian sources — have periodically appeared on import alerts. Importers should check FDA's import alert database before placing orders and request current cGMP compliance documentation from suppliers.
FDA distinguishes between APIs, intermediates, and finished drug products for regulatory purposes, but all require the foreign manufacturer to be registered with FDA under the Drug Supply Chain Security Act (DSCSA) framework. Partially formulated penicillin preparations may still require a drug master file (DMF) reference and cGMP compliance documentation. Customs classification and FDA regulatory status should both be confirmed before importation.
Subheading 6 of 10 in heading 3003
Subheading 300310 · $97K of $139.8M
ImportsExports
Imports
—YoY · free account
Exports
$97KYoY · free account
Low of 7 reported months · imports
Low · free accountOver the twelve months to August 2026, the U.S. imported $3.6M of Medicaments Containing Penicillins or Penicillin Derivatives and exported $918K.
Fewer than 6 of the last 12 months reported trade, or the latest month was under $500K; the trend chart is not shown for thin series.
Through August 2026 · imports 7 of 12 months reported. Source: U.S. Census Bureau.
Trade Directory
List your company under HS 300310 — Medicaments Containing Penicillins or Penicillin Derivatives, so the companies trading it can find you. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Imports for consumption | Average duty rate | Dutiable Share |
|---|---|---|---|---|
| 3003100000 | Medicaments Cont Penicillins or Derivatives Etc | — | -- | -- |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3003100000 | Medicaments Cont Penicillins or Derivatives Etc | $97K |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
Exports · August 2026
destination
Micronesia (Federated States of) and Marshall Islands together take 70% of it.
customs district
origin
entry
rate provision · imports
None recorded for this period.